Commercial Credit Report for Alfresa Holdings Corporation

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Alfresa Holdings Corporation is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Alfresa Holdings Corporation
23F, Ote Center Bldg., 1-1-3, Ote-machi
Phone: +81 352195100p:+81 352195100	CHIYODA-KU, TKY 100-0004 Japan	Ticker: 27842784

Business Summary

Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.

(Source: F-4)

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	3/31/2023	Yes	-	-	-	-

Industries

SIC Code	Description
5122	Drugs, drug proprietaries, and druggists' sundries
3841	Surgical and medical instruments and apparatus
6411	Insurance agents, brokers, and service
2835	In vitro and in vivo diagnostic substances
2834	Pharmaceutical preparations
4225	General warehousing and storage
5912	Drug stores and proprietary stores
6531	Real estate agents and managers
6719	Offices of holding companies, not elsewhere classified
5047	Medical, dental, and hospital equipment and supplies

Officers and Directors

Title	Name	Age	Title Date	Start Date
President, Representative Director	RyujiArakawa	50	6/1/2020	6/1/2007
President of Subsidiary, Director	HisashiKatsuki	67	1/1/2021	6/1/2017
Chairman & President of Subsidiaries, Director	KoichiShimada	64	6/1/2018	6/1/2018
11 additional Officers and Directors records available in full report.

Subsidiaries

Business Name	Address	City	State/Province	Country
Tokiwa Yakuhin Co Ltd.	860-1, Tsumazakigaisaku	Ube		Japan

Business Names

Business Name
2784
Alfresa Healthcare Corporation
Alfresa Holdings Corporation
Tokiwa Yakuhin Co., Ltd.

General Information

Number of Employees:	11,772	(As of 3/31/2023)
Outstanding Shares:	186,869,741	(As of 12/31/2023)
Shareholders:	12,958
Stock Exchange:	TYO
Fax Number:	+81 352195103

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN